NASDAQ
Centessa Pharmaceuticals plc (CNTA) has a free cash flow growth of -29.39% as of Friday, May 29, 2026. This represents a 8.03% increase compared to its 12-month average of -31.96%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.